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Heart TransplantationThree-Dimensional Self-Navigated T2 Mapping for
the Detection of Acute Cellular Rejection After
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Background. T2 mapping is a magnetic resonance imaging technique measuring T2 relaxation time, which increases with the
myocardial tissue water content. Myocardial edema is a component of acute cellular rejection (ACR) after heart transplantation.
This pilot study compares in heart transplantation recipients a novel high resolution 3-dimensional (3D) T2-mapping technique with
standard 2-dimensional (2D) T2-mapping for ACR detection.Methods.Consecutive asymptomatic patients (n = 26) underwent
both 3D T2 mapping and reference 2D T2 mapping magnetic resonance imaging on the day of endomyocardial biopsy (EMB). 3D
T2 maps were obtained at an isotropic spatial resolution of 1.72 mm (voxel volume 5.1 mm
3). 2D and 3D maps were matched
anatomically, and maximum segmental T2 values were compared blinded to EMB results. In addition, all 3D T2 maps were ren-
dered as 3D images and inspected for foci of T2 elevation.Results. T2 values of segments from 2D and reformatted 3D T2 maps
agreed (p > 0.5). The highest 2D segmental T2 values were 49.9 ± 4.0 ms (no ACR = 0R, n = 18), 48.9 ± 0.8 ms (mild ACR = 1R,
n = 3), and 65.0ms (moderate ACR = 2R). Rendered 3D T2maps of cases with 1R showed foci with significantly elevated T2 signal
(T2 = 58.2 ± 3.6 ms); 5 cases (28%) in the 0R group showed foci with increased T2 values (>2 SD above adjacent tissue) that were
not visible on the 2D T2maps.Conclusions.This pilot study in a small cohort suggests equivalency of standard segmental anal-
ysis between 3D and 2D T2-mapping. 3D T2 mapping provides a spatial resolution that permits detection of foci with elevated T2 in
patients with mild ACR.
(Transplantation Direct 2017;3: e149; doi: 10.1097/TXD.0000000000000635. Published online 28 March, 2017.)The International Society ofHeart and Lung Transplanta-tion registry indicates that 25% of adult heart trans-
plant (HTx) recipients have 1 or more episodes of acute
cellular rejection (ACR) within the first postoperative year.1Received 19 September 2016. Revision requested 25 September 2016.
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Transplantation DIRECT ■ 2017ACR accounts directly for 4% of posttransplant mortality
and may also play a causal role for primary graft failure,
which entails 22% of deaths after HTx.1 Histological grad-
ing of endomyocardial biopsies (EMB) remains the standard
surveillance for detection of ACR.However, the sensitivity of
EMB for detection of ACR is limited to 70%, as indicated byEmma Muschamp Foundation and the Swiss National Science Foundation
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with autopsy findings.2-4 Furthermore, there is a specificity
concern, because concordance of histological grading by dif-
ferent pathologists was only 71% in the 937 EMBs obtained
by the cardiac allograft rejection gene expression observa-
tional study II trial.5
In an animal model of heart transplant rejection, the T2 re-
laxation time, a physiological property of a given tissue in a
magnetic field, increased with the severity of rejection and
in linear relationship with the myocardial tissue water con-
tent.6 Compatible with these observations, the International
Society of Heart and Lung Transplantation ACR grading rec-
ommendations require the presence of edema for diagnosing
severe rejection (3R), but not in mild (1R) or moderate (2R)
ACR.7 This does not exclude the presence of edema in human
low-grade ACR but acknowledges that standard processing
of EMB for histological reading does not permit reliable de-
tection of minor quantities of interstitial edema.
At present, ACR detection in HTx recipients on the basis
of fast breath-held 2-dimensional (2D) T2 mapping at a mag-
netic field strength of 1.5 T permits analysis of 3 slices of
10-mm thickness with a spatial resolution of 1.9  2.5 
8 = 37 mm3 or greater. This technique can be used to very ac-
curately detect 2R or greater ACR, which histologically pre-
sents with multifocal or diffuse infiltration of the whole
heart.8 Mild rejection with its patchy nature, however, re-
quires whole-heart screening with high spatial resolution
for reproducible discrimination of edematous from adjacent
nonedematous tissue.9 Though the clinical relevance of 1R
may be argued,1 its high incidence and the risk for progres-
sion to more severe ACR10 provide a strong argument for
its noninvasive detection. Furthermore, absence of ACR
when using a technique that is able to detect 1R will impact
on the guidance of immunosuppression. This pilot study
therefore aimed to validate a novel 3-dimensional (3D) self-
navigated cardiac T2-mapping technique with high spatial
resolution (1.72 x 1.72 x 1.72 = 5.1 mm3) at 3 T throughout
the whole heart11 by direct comparison with 2D T2-mapping
at high resolution (1.25 1.25 5 = 7.8 mm3)12 and EMB-
based ACR detection.
MATERIALS AND METHODS
Approval from the local ethics committee was obtained
(protocol 250/2013). All participants provided writtenTABLE 1.
An overview of the used MRI parameters
Parameter 2D T2
No. maps per scan
Pulse sequence basis Radia
Echo time TE, ms
Repetition time TR, ms
Total radial readouts per image (−) 31
T2 preparation durations, ms 0/30
Flip angle, degrees 1
Spatial resolution, mm3 1.2  1.2
Respiratory motion compensation Lung-liver
readouts per heartbeat (−) 2
Total acquisition duration ~3  5 min (depending on the r
GRE, gradient echo; bSSFP, balanced steady-state free precession.informed consent. A total of 26 consecutive asymptomatic
HTx recipients in stable phase afterHTx (55–4275 days) were
included (mean age, 52 ± 9 years; 3 women; mean donor age,
42 ± 12 years; time after HTx, 699 ± 674 days). Immunosup-
pression was always guided by EMB histology; coronary an-
giograms showed no relevant coronary vasculopathy.
Magnetic resonance imaging (MRI) was performed on the
day of EMB procurement using a clinical magnetic resonance
scanner with a magnetic field strength of 3 T (Magnetom
Trio, Siemens Healthcare) and with a 32-channel radio-
frequency coil. High-resolution navigator-gated radial 2D
T2 maps
12 were acquired in 3 short-axis slices as a reference
(see Table 1 for magnetic resonance pulse sequence details).
The self-navigated isotropic 3D radial whole-heart T2
map11 (voxel size 1.72 x 1.72 x 1.72 = 5.1mm3 )was obtained
during free breathing. Acquisition, processing and reading of
the MRI results was performed with the observer blinded to
EMB results.
Segments of 2D and 3D T2 maps were manually drawn in
accordance with current AHAguidelines13 after reformatting
and slice-thickness matching of the latter. Equivalency of 3D
with reference 2D T2 mapping was tested comparing the
highest segmental 2D and 3D T2 values in groups of HTx re-
cipients without (0R), mild (1R), or moderate/severe ACR
(≥2R). In addition, all 3D T2 maps were rendered as 3D im-
ages (Figure 1) and inspected for foci of T2 elevation.
All values are represented as mean ± SD T2 values were
compared with a 2-sided paired Student’s t-test with
Bonferroni correction for multiple comparisons, with P less
than 0.05 considered significant. In case of a single value in
a group, standard deviation or P value was not calculated.
RESULTS
Mild ACR was present in 3 patients, 1 patient had 2R;
no EMB showed immunohistological signs of acute humoral
rejection. Four 3D T2 maps were discarded due to insuffi-
cient image quality. Mean T2 values of segments from 2D
and reformatted 3D T2 maps agreed well: the highest 2D
and 3D segmental T2 values of the 3 ACR groups were
49.9 ± 4.0 ms versus 49.1 ± 3.8 ms (0R), 48.9 ± 0.8ms versus
49.2 ± 1.3 ms (1R), and 65.0 ms versus 66.1 ms (2R)
(P > 0.51 for all comparisons). However, rendered 3D T2
maps of the 3 cases with 1R showed foci with significantly el-
evated T2 (T2 = 58.2 ± 3.6 ms) that were not visible onmaps 3D T2 maps
3 1
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FIGURE 1. 3D and 2D T2 maps of patients with ACR 0R, 1R, and 2R. A-C, Examples of volume-rendered 3D T2 maps that were segmented
along the center of the endocardium of the LV. D-F, Corresponding basal 2D T2 maps. The 3D T2 maps of patients with 1R show patches with
significantly elevated T2 values (black arrow). The color bar indicates T2 values in ms.
© 2017 Wolters Kluwer van Heeswijk et al 3respective 2D T2 maps (Figures 1B, E). In addition, rendered
T2 maps from 5/18 patients (28%) without ACR in the EMB
showed foci with increased T2 values with greater than 2
standard deviations of difference when compared with
adjacent tissue and similar to foci detected in patients with
1R ACR (Figure 1B, black arrow). The 3D T2 map of the
single 2R case showed elevated T2 values throughout the
left ventricle (LV) in a relatively heterogeneous pattern
(Figure 1C).DISCUSSION
This pilot studywith 26 consecutive asymptomatic HTx re-
cipients presenting for a scheduled control biopsy demon-
strates corresponding segmental T2 values in 2D and 3D T2
maps of patients with 0R and 1R, indicating equivalency of
the novel 3D T2 mapping algorithm with the actual T2 map-
ping standard. Furthermore, rendered 3DT2map showed foci
with significantly increased T2 values compatible with local
ACR in all patients with EMB-proven ACR suggesting that
this novel algorithm has the potential to detect ACR with a
sensitivity that is noninferior to the criterion standard of
ACR detection. Consistent with previous studies,8 the 2R case
demonstrated throughout the whole LV elevated T2 values
that were several standard deviations above the 0R value.
Retrospective analysis of the 4 discarded maps showed
that the main cause of insufficient image quality was most
likely insufficient communication with the performing tech-
nologist, because in 3 of the 4 patients, only routine shim-
ming was performed, whereas cardiac shimming is essential
for balanced steady-state free precession–based cardiac pulse
sequences at 3 T.14 This resulted in several dark-band arti-
facts (banded signal voids) through the heart, which in turn
caused the self- navigation to perform suboptimally. In addi-
tion, in 2 of the 4 patients, the timing was most likely not setto the correct phase of the heart, resulting in too noisy and
blurred data.
In this pilot study, rendered 3D T2 maps showed foci with
significantly elevated T2 values in 28% of patients without
histological signs of ACR in the EMB. Moreover, the respec-
tive 2D T2 mapping segments in these study patients did not
show elevated T2 values compared to adjacent segments.
This observation may suggest superior sensitivity of 3D T2
mapping when compared with histological grading of EMBs
or 2D T2 mapping. In fact, both techniques have inherent
major methodological limitations that decrease their sensitiv-
ity for mild ACR detection: in particular, sampling error re-
lated to EMB procurement and dilution of the T2 values of
increased intensity in a larger voxel volume. The results of
this pilot study therefore encourage the investigation of the
hypothesis that 3D T2 mapping may allow for noninvasive
detection of mild ACR. However, this hypothesis needs vali-
dation in a larger patient cohort and should use concomitant
intragraft gene expression analysis to prove the presence of
ACR in patients with foci of increased T2 values but negative
histology in the EMB.
The guidelines for the care of heart transplant patients rec-
ommend adjustments of maintenance immunosuppressive
therapy only in HTx recipients with moderate or severe
ACR,5 which may argue the prognostic benefit associated
with the detection of mild ACR. However, intragraft gene
expression analysis indicates that the gene expression profile
of histological grade 1R ACR is close to the profile of 2R
ACR in almost half of all cases.10 Because ACR≥2R is asso-
ciated with a decrease in survival after HTx,15,16 adjustment
of the strength of ongoing maintenance immunosuppressive
therapy in patients with 1R ACR might be beneficial, and
3D T2 mapping might be a useful tool for noninvasive detec-
tion of mild ACR. However, before HTx recipients are ex-
posed to the risks associated with increased strength of
immunosuppression, a critical appraisal of the prognostic
4 Transplantation DIRECT ■ 2017 www.transplantationdirect.comrelevance of focally increased T2 values is mandatory in a
longitudinal follow-up study of HTx patients with EMB-
guided immunosuppression.
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